CervoMed is a Boston biotechnology company developing neflamapimod, an oral drug candidate for age-related brain disorders. It last closed at $1.46 on Nov 20, up 9.77% on the day. The next earnings report for CRVO is expected around Tue, Mar 16, 2027, after the close. For the quarter ended Sep 2026, CRVO reported EPS of -$0.39 on revenue of $0, with revenue down 100.0% from a year ago. Over its last 8 reports the stock moved an average of 4.1% the session after earnings. Over the last 12 months CRVO insiders bought $3.2M of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is CRVO in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CRVO.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on CRVOStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
CRVO · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 13% below its 20 day and 53% below its 50 day average. It is 118% below its 200 day average, so the longer trend is down. Momentum is neutral (RSI 37), near oversold. The nearest support is the Pivot S1 at $1.36, and the nearest resistance the Pivot at $1.50.
Short trendBearish
Long trendBearish
MomentumNeutral
StretchNear oversold
VolatilityHigh, 15.9%/day
Key levels
$10.0052 week high+584.9%
$3.19200 day average+118.5%
$2.53100 day average+73.3%
$2.2450 day average+53.4%
$2.20Swing high (Nov 12)+50.7%
$1.6620 day average+13.7%
$1.61Pivot R1+10.3%
$1.50Pivot+2.7%
$1.46Last close
$1.36Pivot S1−6.8%
$1.2752 week low−13.0%
$1.27Swing low (Nov 6)−13.0%
Indicators
RSI (14)
37.30
Weak, oversold below 30
Neutral
MACD
-0.23
Above its signal line
Bullish
Stochastic
15.4
Near the bottom of its range
Oversold
ADX (14)
24.8
Weak trend
Williams %R
-79.6
Oversold below −80, overbought above −20
Neutral
CCI (20)
-56.4
Oversold below −100, overbought above 100
Neutral
Rate of change
+2.8%
Change over 10 sessions
Bullish
ATR (14)
$0.23
Typical daily range, 15.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 44.1%/day
Key levels
$10.0052 week high+584.9%
$3.19200 day average+118.5%
$2.53100 day average+73.3%
$2.2450 day average+53.4%
$2.20Swing high (Nov 12)+50.7%
$1.6620 day average+13.7%
$1.61Pivot R1+10.3%
$1.50Pivot+2.7%
$1.46Last close
$1.36Pivot S1−6.8%
$1.2752 week low−13.0%
$1.27Swing low (Nov 6)−13.0%
Indicators
RSI (14)
34.06
Weak, oversold below 30
Neutral
MACD
-0.61
Below its signal line
Bearish
Stochastic
11.7
Near the bottom of its range
Oversold
ADX (14)
16.0
No clear trend
Williams %R
-91.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-162.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−43.2%
Change over 10 sessions
Bearish
ATR (14)
$0.64
Typical daily range, 44.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CRVO
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how CRVO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow CRVO usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for CRVOHow many large options trades hit CRVO, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in CRVO in the last 90 days.
From SEC Form 4 filings by CRVO's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CRVO is in one of them and how their past CRVO trades turned out.
CervoMed is a biotechnology company based in Boston, Massachusetts, that is developing treatments for brain disorders linked to aging. Its lead candidate, neflamapimod, is an oral drug designed to reduce brain inflammation and address problems with communication between nerve cells. The drug is in clinical trials for dementia with Lewy bodies and is also being studied for other neurological conditions, including ALS. The company does not yet have an approved product, and its intended users are patients with these conditions.